SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Truist Raises Kymera Therapeutics Price Target to $150 From $136

Valid market news retained in the public archive without immediate LiveCast distribution.

KYMR

Related stories